Let's work together to build and deliver transformative cancer therapies.
PARTNER WITH US.
Explore how we may be able to collaborate and leverage each of our companies knowledge and experience to achieve amazing synergy.
Engage in licensing opportunities of our patented mTEV platform to enhance your checkpoint inhibitor candidate for new clinical indications.
Work together to develop and commercialize a therapy of mutual benefit.
Execute EV Therapeutics vision of democratizing immunotherapy by financially supporting our core mission.